Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-24

Clinical Trial Update: A Trial of YPEG-rhGH in Children With Short Stature [Phase 2]

View source ↗

Summary

Phase 2 trial update for YPEG-rhGH in children with short stature, including idiopathic short stature and small for gestational age conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • YPEG-rhGH (YPEG-rhGH)

Snippet

Sponsor: Xiamen Amoytop Biotech Co., Ltd. | Conditions: Idiopathic Short Stature, Small for Gestational Age | Phase 2 | Status: COMPLETED